Novo Nordisk A/S: Share repurchase programme
Bagsværd, Denmark, 31 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14 billion to be executed during a 12-month period beginning 1 February 2018.
Further information
Media: | ||
Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
Ken Inchausti (US) | +1 609 240 9429 | kiau@novonordisk.com |
Investors: | ||
Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
Anders Mikkelsen | +45 3079 4461 | armk@novonordisk.com |
Valdemar Borum Svarrer | +45 3079 0301 | jvls@novonordisk.com |
Company announcement No 82
Attachment
Upcoming Life Sciences Events
- May 2024
- London: London BioTechnology Show 2024
- Seoul: BIO KOREA 2024
- Biotechgate Digital Partnering May 2024
Latest company news
There are currently no news available for this portal